Home Cart Sign in  
Chemical Structure| 50851-01-9 Chemical Structure| 50851-01-9

Structure of 50851-01-9

Chemical Structure| 50851-01-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 50851-01-9 ]

CAS No. :50851-01-9
Formula : C14H12N2OS
M.W : 256.32
SMILES Code : NC1=NC2=CC=C(OCC3=CC=CC=C3)C=C2S1
MDL No. :MFCD09755107
InChI Key :DBWISUPGDHAXIT-UHFFFAOYSA-N
Pubchem ID :17244953

Safety of [ 50851-01-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of [ 50851-01-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 50851-01-9 ]

[ 50851-01-9 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 50851-01-9 ]
  • [ 87-13-8 ]
  • [ 50850-71-0 ]
  • 2
  • [ 50851-01-9 ]
  • [ 100493-31-0 ]
  • 3
  • [ 50851-01-9 ]
  • (2S,3S)-8-Benzyloxy-3-hydroxy-2-p-tolyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one [ No CAS ]
  • 4
  • [ 50851-01-9 ]
  • (2S,3S)-8-Benzyloxy-3-hydroxy-2-(4-methoxy-phenyl)-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one [ No CAS ]
  • 5
  • [ 50851-01-9 ]
  • (2R,3R)-8-Benzyloxy-5-(2-dimethylamino-ethyl)-3-hydroxy-2-p-tolyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one [ No CAS ]
  • 6
  • [ 50851-01-9 ]
  • Carbonic acid (2R,3R)-8-benzyloxy-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester ethyl ester [ No CAS ]
  • 7
  • [ 50851-01-9 ]
  • [2-((2S,3S)-8-Benzyloxy-3-hydroxy-4-oxo-2-p-tolyl-3,4-dihydro-2H-benzo[b][1,4]thiazepin-5-yl)-ethyl]-methyl-carbamic acid benzyl ester [ No CAS ]
  • 8
  • [ 50851-01-9 ]
  • Acetic acid (2S,3S)-8-benzyloxy-5-[2-(benzyloxycarbonyl-methyl-amino)-ethyl]-4-oxo-2-p-tolyl-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester [ No CAS ]
  • 9
  • [ 50851-01-9 ]
  • Acetic acid (2R,3R)-5-(2-dimethylamino-ethyl)-8-hydroxy-4-oxo-2-p-tolyl-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrobromide [ No CAS ]
  • 10
  • [ 50851-01-9 ]
  • 4-Nitro-benzoic acid (2R,3R)-8-benzyloxy-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester [ No CAS ]
  • 11
  • [ 50851-01-9 ]
  • Acetic acid (2R,3R)-8-hydroxy-2-(4-methoxy-phenyl)-5-(2-methylamino-ethyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrobromide [ No CAS ]
  • 12
  • [ 50851-01-9 ]
  • Acetic acid (2R,3R)-5-(2-dimethylamino-ethyl)-8-hydroxy-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrobromide [ No CAS ]
  • 13
  • [ 50851-01-9 ]
  • Carbonic acid (2R,3R)-5-(2-dimethylamino-ethyl)-8-hydroxy-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester ethyl ester; hydrobromide [ No CAS ]
  • 14
  • [ 50851-01-9 ]
  • Acetic acid (2R,3R)-8-benzyloxy-2-(4-methoxy-phenyl)-5-(2-methylamino-ethyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrobromide [ No CAS ]
  • 15
  • [ 50851-01-9 ]
  • 4-Nitro-benzoic acid (2R,3R)-5-(2-dimethylamino-ethyl)-8-hydroxy-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrobromide [ No CAS ]
  • 16
  • [ 50851-01-9 ]
  • (2S,3S)-5-(2-Dimethylamino-ethyl)-3,8-dihydroxy-2-p-tolyl-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one [ No CAS ]
  • 17
  • [ 50851-01-9 ]
  • (+/-)-(2S,3S)-5-(2-(dimethylamino)ethyl)-3,8-dihydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one [ No CAS ]
  • 18
  • [ 50851-01-9 ]
  • (2R,3R)-8-Benzyloxy-5-(2-dimethylamino-ethyl)-3-hydroxy-2-(4-methoxy-phenyl)-2,3-dihydro-5H-benzo[b][1,4]thiazepin-4-one [ No CAS ]
  • 19
  • [ 50851-01-9 ]
  • (+/-)-8-Benzyloxydiltiazem [ No CAS ]
  • 20
  • [ 100-02-7 ]
  • [ 50851-01-9 ]
  • 21
  • [ 6373-46-2 ]
  • [ 1147550-11-5 ]
  • [ 50851-01-9 ]
YieldReaction ConditionsOperation in experiment
20% With bromine; In formic acid; acetic acid; at -3 - 0℃;Inert atmosphere; Darkness; General procedure: The synthesis of 6-ethoxy-1,3-benzothiazol-2-amine (1c), obtained following a general procedure for the preparation of aminobenzothiazoles described in the literature [13,14] is described. Aniline 6c (1.0 g, 7.36 mmol) and NH4SCN (1.6 g, 21.9 mmol) were dissolved in a 20% formic acid-glacial acetic acid mixture (100 mL) and cooled to-3 C with stirring, under N2. With the exclusion of light from the reaction mixture, bromine (0.30 mL dissolved in 20 mL of glacial acetic acid) was added dropwise, while the reaction temperature was kept between -3C and 0 C. The light shield was removed and the mixture was allowed to warm to room temperature overnight. Sodium hydroxide pellets and ice were added with stirring until pH 11 was attained, and the mixture was extracted with EtOAc. The organic layer was separated and filtered through celite to remove polythiocyanogen (SCN)n. The organic layer was then washed with water, saturated NaHCO3 and brine; then, the solvent was evaporated in vacuo. The residue was purified by flash chromatography (EtOAc/petroleum ether 1:1) to give 0.93 g (65%) of an orange solid:
  • 22
  • [ 100-51-6 ]
  • [ 50851-01-9 ]
  • 23
  • [ 1145-76-2 ]
  • [ 50851-01-9 ]
  • 25
  • [ 50851-01-9 ]
  • 2-((1H-1,2,4-triazol-3-yl)thio)-N-(6-(benzyloxy)benzo[d]thiazol-2-yl)acetamide [ No CAS ]
  • 26
  • [ 50851-01-9 ]
  • [ 79-04-9 ]
  • C16H13ClN2O2S [ No CAS ]
YieldReaction ConditionsOperation in experiment
In acetone; at 20℃;Cooling; General procedure: 6-Alkoxy-2-aminobenzothiazoles (3a-m) (20 mmol) was dissolved in 30 mL acetone and 30 mmolof chloroacetyl chloride were added under cold conditions. The reaction was stirred for 9-10 h atroom temperature. Water was added to the reaction mixture after the solvent (acetone) was removedunder pressure-reducing conditions. The mixture was stirred for 0.5 h and filtered to yield a crudeproduct. It was then purified by silica gel column chromatography with dichloromethane to yield awhite solid 4a-m.
  • 27
  • [ 26278-79-5 ]
  • [ 100-44-7 ]
  • [ 50851-01-9 ]
YieldReaction ConditionsOperation in experiment
With N-benzyl-N,N,N-triethylammonium chloride; potassium carbonate; In acetone;Reflux; General procedure: A mixture of compound 2 (2 g, 12 mmol), potassium carbonate (2 g, 14.4 mmol), appropriate alkylbromide or benzyl chloride derivatives (1.32 mmol), and a catalytic amount of benzyltriethylaminechloride (TEBA) in 50 mL acetone was heated under reflux for 18-24 h. After removing the solventunder reduced pressure, 80 mL of hot water was poured into the flask and the mixture was stirred for0.5 h to eliminate the excess of potassium carbonate. The remaining precipitate was filtered to yield arusset solid (3a-m), which was used without further purification.
  • 28
  • [ 50851-01-9 ]
  • C24H17N3O2S [ No CAS ]
  • 29
  • [ 50851-01-9 ]
  • C22H19N3OS [ No CAS ]
  • 30
  • [ 50851-01-9 ]
  • C14H13N3OS [ No CAS ]
  • 31
  • [ 50851-01-9 ]
  • (E)-2-((1-(6-(benzyloxy)benzo[d]thiazol-2-yl)-3-phenyl-1H-pyrazol-4-yl)methylene)hydrazinecarboximidamide [ No CAS ]
  • 32
  • [ 26278-79-5 ]
  • [ 100-39-0 ]
  • [ 50851-01-9 ]
  • 33
  • [ 106-51-4 ]
  • [ 50851-01-9 ]
YieldReaction ConditionsOperation in experiment
General procedure: Sodium thiocyanate (0.37 g,4.5 mmol) was dissolved in MeOH (5 ml_) and cooled to 0 C. Bromine 190 mI_,3.69 mmol) was added slowly dropwise and the reaction stirred for 5 mins. 4-(2- fluorophenoxy)aniline (0.50 g,2.45 mmol) was added,and reaction mixture allowed to warm to r.t. and stirred for 18h. The solution was concentrated in vacuo,and the residue partitioned between DCM and sat. aq. NaHC03. The aqueous layer was extracted with DCM. The combined organics were dried (phase separator) and concentrated in vacuo. The residue was purified by chromatography (S1O2,0- 50% EtOAc in PE) to yield the title compound as a yellow solid (441 mg,69 %).1H NMR 6H (500 MHz,CDCI3) 7.51 (d,J = 8.8 Hz,1 H),7.23 (d,J = 2.5 Hz,1 H),7.22 - 7.18 (m,1 H),7.14 - 7.09 (m,2H),7.07 - 7.00 (m,2H),5.89 - 5.17 (br s,2H); LCMS: (Method A) 3.28 min,(261 .3,MH+).
  • 35
  • [ 50851-01-9 ]
  • 2,2-dimethyl-4H-[1,3]dioxino[5,4-b]pyridin-4-one 2,2,2-trifluoroacetate [ No CAS ]
  • N-(6-(benzyloxy)benzo[d]thiazol-2-yl)-3-hydroxypicolinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
28% With sodium hexamethyldisilazane; In tetrahydrofuran; at 20℃; for 3h; To a mixture of Intermediate BL (50 mg,0.20 mmol) and Intermediate F (86 mg,0.29 mmol) in THF (2 mL) at r.t. was added sodium bis(trimethylsilyl)amide solution (2M in THF) (0.39 ml_,0.78 mmol). The mixture stirred for 3h,then quenched with water. The resultant suspension was filtered,and the solid washed (water),slurried (EtOH) and dried under vacuum to afford the title compound as an orange solid (21 mg,28 %). NMR dH(500 MHz,DMSO-d6) 12.21 (br s,1 H),1 1 .03 (br s,1 H),8.24 (s,1 H),7.73 (d,J = 2.5 Hz,1 H),7.71 (d,J = 8.9 Hz,1 H),7.61 (dd,J = 8.5,4.4 Hz,1 H),7.53 (d,J = 8.5 Hz,1 H),7.50 - 7.45 (m,2H),7.44 - 7.37 (m,2H),7.37 - 7.30 (m,1 H),7.15 (dd,J = 8.8,2.6 Hz,1 H),5.16 (s,2H); LCMS (Method A): 2.60 min,(378.1 MH+).
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 50851-01-9 ]

Aryls

Chemical Structure| 89539-55-9

A506455 [89539-55-9]

2-Amino-6-(benzyloxy)benzo[d]thiazol-5-ol

Similarity: 0.95

Chemical Structure| 89539-57-1

A268557 [89539-57-1]

6-(Benzyloxy)-2-(methylamino)benzo[d]thiazol-5-ol

Similarity: 0.88

Chemical Structure| 1000289-66-6

A564043 [1000289-66-6]

5-(Benzyloxy)-7-bromobenzo[d]thiazol-2-amine

Similarity: 0.86

Ethers

Chemical Structure| 89539-55-9

A506455 [89539-55-9]

2-Amino-6-(benzyloxy)benzo[d]thiazol-5-ol

Similarity: 0.95

Chemical Structure| 89539-57-1

A268557 [89539-57-1]

6-(Benzyloxy)-2-(methylamino)benzo[d]thiazol-5-ol

Similarity: 0.88

Chemical Structure| 1000289-66-6

A564043 [1000289-66-6]

5-(Benzyloxy)-7-bromobenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 14372-64-6

A890545 [14372-64-6]

6-Propoxybenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 15850-81-4

A729740 [15850-81-4]

6-Isopropoxybenzo[d]thiazol-2-amine

Similarity: 0.86

Amines

Chemical Structure| 89539-55-9

A506455 [89539-55-9]

2-Amino-6-(benzyloxy)benzo[d]thiazol-5-ol

Similarity: 0.95

Chemical Structure| 89539-57-1

A268557 [89539-57-1]

6-(Benzyloxy)-2-(methylamino)benzo[d]thiazol-5-ol

Similarity: 0.88

Chemical Structure| 1000289-66-6

A564043 [1000289-66-6]

5-(Benzyloxy)-7-bromobenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 14372-64-6

A890545 [14372-64-6]

6-Propoxybenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 15850-81-4

A729740 [15850-81-4]

6-Isopropoxybenzo[d]thiazol-2-amine

Similarity: 0.86

Related Parent Nucleus of
[ 50851-01-9 ]

Benzothiazoles

Chemical Structure| 89539-55-9

A506455 [89539-55-9]

2-Amino-6-(benzyloxy)benzo[d]thiazol-5-ol

Similarity: 0.95

Chemical Structure| 89539-57-1

A268557 [89539-57-1]

6-(Benzyloxy)-2-(methylamino)benzo[d]thiazol-5-ol

Similarity: 0.88

Chemical Structure| 1000289-66-6

A564043 [1000289-66-6]

5-(Benzyloxy)-7-bromobenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 14372-64-6

A890545 [14372-64-6]

6-Propoxybenzo[d]thiazol-2-amine

Similarity: 0.86

Chemical Structure| 15850-81-4

A729740 [15850-81-4]

6-Isopropoxybenzo[d]thiazol-2-amine

Similarity: 0.86